Cho Yeow Koh and colleagues recently published an article on the efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors in Nature Communications. Here we summarize their work, which is also publicly available on Nature.com. Procedures like percutaneous coronary intervention (PCI) increase thrombin generation that results in clotting, which must be combatted using anticoagulants. Common…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest